These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10516503)

  • 1. Matrix metalloproteinase-2 and mesangiolysis in diabetic nephropathy.
    Kanauchi M; Nishioka H; Kawano T; Uyama H; Shiiki H; Dohi K
    Nephron; 1999; 83(2):174-5. PubMed ID: 10516503
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesangiolysis in diabetic glomeruli: its role in the formation of nodular lesions.
    Saito Y; Kida H; Takeda S; Yoshimura M; Yokoyama H; Koshino Y; Hattori N
    Kidney Int; 1988 Sep; 34(3):389-96. PubMed ID: 3172647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M; Takemura T; Yanagida H; Yoshioka K
    Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient morphometric analysis of glomerular mesangium in insulin-dependent diabetic patients with early nephropathy. The European Study of the Progression of Renal Disease in Type 1 (Insulin Dependent) Diabetes (ESPRIT) Study Group.
    MacLeod JM; White KE; Tate H; Bilous RW
    Kidney Int; 1997 May; 51(5):1624-8. PubMed ID: 9150483
    [No Abstract]   [Full Text] [Related]  

  • 5. Nodular lesions and mesangiolysis in diabetic nephropathy.
    Wada T; Shimizu M; Yokoyama H; Iwata Y; Sakai Y; Kaneko S; Furuichi K
    Clin Exp Nephrol; 2013 Feb; 17(1):3-9. PubMed ID: 23100177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular mesangial fibrillary deposits in a patient with diabetes mellitus.
    Gonul II; Gough J; Jim K; Benediktsson H
    Int Urol Nephrol; 2006; 38(3-4):767-72. PubMed ID: 17211574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [History of mesangiolysis, with special reference to research in Japan].
    Morita T
    Nihon Jinzo Gakkai Shi; 2003 Oct; 45(7):667-72. PubMed ID: 14631761
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular and molecular pathomechanisms of diabetic nephropathy.
    Thaiss F; Stahl R
    Clin Investig; 1993 Oct; 71(10):830-3. PubMed ID: 8305843
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal expression of proto-oncogene Ets-1 on matrix remodeling in experimental diabetic nephropathy.
    Liu DX; Liu XM; Su Y; Zhang XJ
    Acta Histochem; 2011 Sep; 113(5):527-33. PubMed ID: 20598359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
    Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathology of diabetic nephropathy].
    Hara M; Takagawa R; Ishida A
    Nihon Rinsho; 1997 Oct; 55 Suppl():783-8. PubMed ID: 9392197
    [No Abstract]   [Full Text] [Related]  

  • 12. Early mesangiolysis and monocyte influx observed in diabetic glomerulosclerosis: relation to nodule formation.
    Koda Y; Maruyama Y; Ogino S; Hayashi H; Nishi S; Saito T; Ueno H; Arakawa M
    Nihon Jinzo Gakkai Shi; 1991 Jan; 33(1):33-42. PubMed ID: 2038130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic nephropathy--clinical picture and treatment guidelines].
    Zander E; Conde N; Precht K; Schulz B
    Z Arztl Fortbild (Jena); 1987; 81(18):933-9. PubMed ID: 3321725
    [No Abstract]   [Full Text] [Related]  

  • 14. [Abnormality of type IV collagen metabolism in the development of diabetic nephropathy].
    Haneda M; Kikkawa R
    Nihon Rinsho; 1992 Dec; 50(12):3016-20. PubMed ID: 1491453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-2 (MMP-2) and membrane-type 1 MMP (MT1-MMP) affect the remodeling of glomerulosclerosis in diabetic OLETF rats.
    Furuichi K; Hisada Y; Shimizu M; Okumura T; Kitagawa K; Yoshimoto K; Iwata Y; Yokoyama H; Kaneko S; Wada T
    Nephrol Dial Transplant; 2011 Oct; 26(10):3124-31. PubMed ID: 21414971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alterations of mesangial cell and matrix].
    Kashihara N; Sato M; Komai N; Sasaki T
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():390-5. PubMed ID: 21661178
    [No Abstract]   [Full Text] [Related]  

  • 17. AJKD Atlas of Renal Pathology: diabetic nephropathy.
    Najafian B; Fogo AB; Lusco MA; Alpers CE
    Am J Kidney Dis; 2015 Nov; 66(5):e37-8. PubMed ID: 26498421
    [No Abstract]   [Full Text] [Related]  

  • 18. [Etiopathogenesis of early stages of diabetic nephropathy].
    Pynka S; Czekolski S
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):830-5. PubMed ID: 2096378
    [No Abstract]   [Full Text] [Related]  

  • 19. LDL-Apheresis for diabetic nephropathy: a possible new tool.
    Kobayashi S
    Nephron; 1998 Aug; 79(4):505-6. PubMed ID: 9689183
    [No Abstract]   [Full Text] [Related]  

  • 20. Beneficial effects of C-peptide on renal morphology in diabetic rats.
    Sun W; Gao X; Zhao X; Cui D; Xia Q
    Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):893-9. PubMed ID: 21106770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.